期刊文献+

去冷沉淀血浆的质量分析 被引量:4

Analysis of quality of cryoprecipitate-reduced plasma
原文传递
导出
摘要 目的比较去冷沉淀血浆(Cryoprecipitate-reduced plasma,CRP)中系列凝血因子、纤维蛋白原(Fibrinogen,Fib)和血管性血友病因子裂解蛋白酶(A disintegrin-like and metalloprotease with thrombospondin-1 repeats 13,ADAMTS-13)水平的变化。方法用140人份新鲜冰冻血浆(Fresh frozen plasma,FFP)制备CRP,采用Biggers一期法测定FFP和CRP中FⅡ、FⅤ、FⅦ、FⅧ、FⅨ、FⅩ、FⅪ、FⅫ的促凝活性;免疫比浊法测定Fib和血管性血友病因子抗原因子活动度(vWF∶Ag)水平;荧光共振能量转移法(Fluorescence resonance energy transfer,FRET)测定70人份FFP和CRP中的ADAMTS13活性及抗原含量。结果与FFP比较,CRP中FⅧ∶C、FⅤ∶C、FⅦ∶C、FⅨ∶C、FⅩ∶C、FⅪ∶C、Fib、vWF∶Ag水平均明显下降,且差异均有统计学意义(P<0.05或<0.001);FⅡ∶C、FⅫ∶C、ADAMTS13抗原含量和活性差异均无统计学意义(P>0.05)。结论 CRP可代替FFP用于血栓性血小板减少性紫癜(Thrombotic throm-bocytopenic purpura,TTP)的治疗,而不适用于FⅧ、Fib及vWF缺乏患者的补充治疗。 Objective To compare the levels of coagulation factors,fibrinogen(Fib) and Von Willebrand factor cleaving protease,a disintegrin-like and metalloprotease with thrombospondin-1 repeats 13(ADAMTS13),in cryoprecipitate-reduced plasma(CRP).Methods CRP was prepared with the fresh frozen plasma(FFP) from 140 donors.The coagulation-promoting activities of FⅡ,FⅣ,FⅦ,FⅧ,FⅨ,FⅩ,FⅪ and FⅫ in FFP and CRP were determined by one-stage Biggers method,while the activities of Fib and Von Willebrand factor antigen(vWF ∶ Ag) by immune turbidimetry.The activity and antigen contents of ADAMTS13 in FFP and CRP were determined by fluorescence resonance energy transfer(FRET) assay.Results As compared with those in FFP,the levels of FⅧ ∶ C,FⅤ ∶ C,FⅦ ∶ C,FⅨ ∶ C,FⅩ ∶ C,FⅪ ∶ C,Fib,vWF ∶ Ag decreased significantly(P 0.05 or P 0.001),while the antigen content and activity of FⅡ ∶ C,FⅫ ∶ C and ADAMTS13 showed no significant difference(P 0.05).Conclusion CRP may be used for treatment of thrombotic thrombocytopenic purpura(TTP) instead of CRP,while is unsuitable for complementary treatment of FⅧ,Fib and vWF deficiency.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第1期81-83,共3页 Chinese Journal of Biologicals
基金 国家卫生公益性行业科研专项(200902008)
关键词 去冷沉淀血浆 凝血因子 纤维蛋白原 血管性血友病因子裂解蛋白酶 血栓性血小板减少性紫癜 Cryoprecipitate-reduced plasma(CRP) Coagulation factor Fibrinogen Von Willebrand factor cleaving protease Thrombotic thrombocytopenic purpura(TTP)
  • 相关文献

参考文献9

  • 1American Association of Blood Banks, American Red Cross, AmericaJs Blood Centers, et ol. Circular of information for the use of human blood and blood components [S]. Washington: Bethesde: American association of blood banks, 2009: 15.
  • 2王憬惺.血液制品学[M].2版,北京:人民卫生出版社,2007:28-38.
  • 3American Association of Blood Banks. Standards for blood banks and transfusion services [S]. Bethesde: American association of blood banks, 2008 : 35.
  • 4Crawley JT, De Groot R, Xiang Y, et ol. Unraveling the seissile bond: how ADAMTS13 recognizes and cleaves yon Willebrand factor [J]. Blood,2011,118 ( 12): 3212-3221.
  • 5Denis CV, Lenting PJ. Von Willebrand factor: at the crossroads of bleeding and thrombosis [J]. Int J Hematol, 2012, 95 (4): 353-361.
  • 6Kobayashi T, Wada H, Kamikura Y, et ol. Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura [J]. Thromb Res, 2007, 119 (4) :447-452.
  • 7黄蓝生,庄文,陈镇奇,林昂.新鲜冰冻血浆、普通冰冻血浆与去冷沉淀血浆部分有效成分的对比[J].血栓与止血学,2011,17(4):169-171. 被引量:27
  • 8陈镇奇,黄蓝生,温国强.冷上清中部分有效成分的检测[J].临床血液学杂志(输血与检验),2011,24(1):78-80. 被引量:4
  • 9Kiman E, Elela AA, ramsis N, et al. Evaluation of the coagulation factors activity of cryosupematant [J]. Suez Canal Univ Med J, 2003.6 (2): 247-258.

二级参考文献4

共引文献28

同被引文献74

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部